Discover a new way to find and share stories you'll love… Learn about Reading Desk

Trend Results : Cancer Center


Blog Post Results (1-20 of 4319)

FILTER RESULTS

IT HAPPENED TO ME: I Went From Cancer Patient To Cancer Research Assistant

7 hours agoLifestyle : xoJane

Hodgkin’s lymphoma inspired me to go back to school for my MSW degree and work in the cancer center where I was treated.

2014 Coaches vs. Cancer Classic: Previews, Predictions for Early-Season Matchups

The Barclays Center in Brooklyn, New York, makes a great setting for four respected college basketball programs playing games for a cause at the 2014 Coaches vs. Cancer Classic. Duke, Temple, Stanford and UNLV will take the court onShow More Summary

Moffitt Cancer Center Researchers Use Evolutionary Principles to Model Cancer Mutations, Discover Potential Therapeutic Targets

Moffitt Cancer Center researchers are taking a unique approach to understanding and investigating cancer by utilizing evolutionary principles and computational modeling to examine the role of specific genetic mutations in the Darwinian struggle among tumor and normal cells during cancer growth.

Moffitt researchers use evolutionary principles to model cancer mutations

TAMPA, Fla. - Moffitt Cancer Center researchers are taking a unique approach to understanding and investigating cancer by utilizing evolutionary principles and computational modeling to examine the role of specific genetic mutations in the Darwinian struggle among tumor and normal cells during cancer growth. read more

Art to Beat Cancer Features More Than 60 Works of Art

Art to Beat Cancer benefits the University of Louisville James Graham Brown Cancer Center.

Montefiore Einstein Center for Cancer Care Receives Avon Foundation Grant to Support Its B.O.L.D. Buddies

Montefiore Einstein Center for Cancer Care and the NCI-designated Albert Einstein Cancer Center announced receipt of a $100,000 grant from the Avon Foundation to support the Bronx Oncology Living Daily Buddy Patient Navigation Progr...

New ‘Hutch’ Director Aims To Push Toward Cancer Cures Based On The Immune System

 This morning, the Fred Hutchinson Cancer Research Center in Seattle, a hotbed for the development of new treatments that harness the immune system against cancer, is announcing that it has hired former Merck cancer research boss Gary Gilliland as its next director. “I’m really excited about this,” said Gilliland, 60, in an interview yesterday. “Immunotherapeutic […]

Memorial Sloan Kettering Team Makes Key Discovery in Understanding Immunotherapy's Successes--and Its Failures

A collaborative team of leaders in the field of cancer immunology from Memorial Sloan Kettering Cancer Center has made a key discovery that advances the understanding of why some patients respond to ipilimumab, an immunotherapy drug, while others do not.

Common Blood Pressure Medication Does Not Increase Risk of Breast Cancer, Intermountain Medical Center Heart Institute Study Finds

Women who take a common type of medication to control their blood pressure are not at increased risk of developing breast cancer due to the drug, according to new study by researchers at the Intermountain Medical Center Heart Institute in Murray, Utah.

Common Blood Pressure Medication Does Not Increase Risk of Breast Cancer, New Study Finds

Women who take a common type of medication to control their blood pressure are not at increased risk of developing breast cancer due to the drug, according to new study by researchers at the Intermountain Medical Center Heart Institute in Murray, Utah.

Scientists have identified a fear-reducing hormone

Researchers have found that oxytocin, known as the bonding hormone, can also reduce fear. Scientists from the Department of Psychiatry and Psychotherapy at the University of Bonn, the German Cancer Research Center, and Chengdu University worked together to research its effects on the fear response. Show More Summary

Immunologist Herman Eisen Dies at 96

Immunologist Herman Eisen, founding member of the MIT Center for Cancer Research, died Nov. 2 at age 96. He is perhaps best known for his early work in describing affinity maturation.

Moffitt Cancer Center Announces Development of Experimental Treatment for Myelodysplastic Syndromes, Autoimmune Diseases

In a major step to treat patients living with Myelodysplastic Syndromes (MDS), a group of diseases that affect the bone marrow and blood, Moffitt Cancer Center today announced the development of an innovative investigational biologic agent that could improve patient response and outcomes for MDS and other diseases.

Delivering Drugs Inside Aggressive Tumors

A multi-disciplinary team of Yale Cancer Center researchers has discovered a promising new method for delivering drugs into aggressive tumors by exploiting a unique feature of tumors themselves. The novel delivery system, described in MicroRNA silencing for cancer therapy targeted to the tumour microenvironment,was published November 17th in the journal Nature.

UNC researchers silence leading cancer-causing gene

CHAPEL HILL, NC - Researchers from the UNC School of Medicine and colleagues at The University of Texas MD Anderson Cancer Center have developed a new approach to block the KRAS oncogene, one of the most frequently mutated genes in human cancer. Show More Summary

Coaches vs. Cancer Classic 2014: Teams, Schedule, Live Stream, Bracket, TV Info

Some of the best college basketball teams in the country will get early tests in the Coaches vs. Cancer Classic. Duke, Stanford, UNLV and Temple will each compete for a title at the Barclays Center on Nov. 21-22, but before that, they will go to battle with two games each on their own campuses. Show More Summary

New Test Developed at Dana-Farber/Brigham and Women's Cancer Center

In a major advance in the care of patients with leukemia and other blood disorders, physicians at Dana-Farber/Brigham and Women's Cancer Center have begun using Rapid Heme Panel, a high-tech genetic test that provides, within a matter of days, an unprecedented amount of critical information to aid the choice of treatment.

Moffitt Cancer Center Researchers Discover Common Chemotherapeutic Agent Reduces Resistance to Virus Therapy in Brain Tumor Patients

Moffitt Cancer Center researchers have found that the common chemotherapeutic agent cyclophosphamide can help improve the success of oncolytic virus therapy in patients with malignant gliomas, a common type of brain tumor. Oncolytic virus therapy is an innovative therapeutic approach that uses viruses to target and kill cancer cells. Show More Summary

Breast cancer survivors to strut runway in Brooklyn

The Pink Runway Fashion Show banks on a bold, beautiful cadre of cancer survivors and doctors, to raise money for the Breast Cancer Center at Maimonides Health Center in Borough Park.

Next-Gen Melanoma Drug, TAK-733, Excels in Lab Tests

A University of Colorado Cancer Center study published online this week in the journal Molecular Cancer Therapeutics reports anti-cancer activity in 10 out of 11 patient tumor samples grown in mice and treated with the experimental drug TAK-733, a small molecule inhibitor of MEK1/2.

Copyright © 2011 Regator, LLC